BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24618035)

  • 41. Differential expression of cell adhesion molecules in B-zone small lymphocytic lymphoma and other well-differentiated lymphocytic disorders.
    Pinto A; Carbone A; Gloghini A; Marotta G; Volpe R; Zagonel V
    Cancer; 1993 Aug; 72(3):894-904. PubMed ID: 8334643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functions of T cells and recruitment of cellular response after in vitro mitogenic stimulation of lymphocytes in chronic lymphocytic leukaemia.
    Neri A; Paciucci PA; Brugiatelli M; Camba L; Comis M; Iacopino P; Nobile F; Lombardo VT
    Ric Clin Lab; 1979; 9(1):67-77. PubMed ID: 158823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-4 (IL-4) enhances homotypic adhesion of activated B-chronic lymphocytic leukaemia (B-CLL) cells via a selective up-regulation of CD54.
    Carlsson M; Söderberg O; Nilsson K
    Scand J Immunol; 1993 Apr; 37(4):515-22. PubMed ID: 8097058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
    Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
    Rezvany MR; Jeddi-Tehrani M; Biberfeld P; Söderlund J; Mellstedt H; Osterborg A; Rabbani H
    Br J Haematol; 2001 Nov; 115(2):263-71. PubMed ID: 11703320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine models for chronic lymphocytic leukaemia.
    Michie AM; Nakagawa R; McCaig AM
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1009-12. PubMed ID: 17956265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
    den Boer ML; Cario G; Moorman AV; Boer JM; de Groot-Kruseman HA; Fiocco M; Escherich G; Imamura T; Yeoh A; Sutton R; Dalla-Pozza L; Kiyokawa N; Schrappe M; Roberts KG; Mullighan CG; Hunger SP; Vora A; Attarbaschi A; Zaliova M; Elitzur S; Cazzaniga G; Biondi A; Loh ML; Pieters R;
    Lancet Haematol; 2021 Jan; 8(1):e55-e66. PubMed ID: 33357483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease.
    Rubino V; Carriero F; Palatucci AT; Giovazzino A; Leone S; Nicolella V; Calabrò M; Montanaro R; Brancaleone V; Pane F; Chiurazzi F; Ruggiero G; Terrazzano G
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
    Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
    Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of casein kinase 1 in the amoeboid migration of B-cell leukemic and lymphoma cells: A quantitative live imaging in the confined environment.
    Čada Š; Vondálová Blanářová O; Gömoryová K; Mikulová A; Bačovská P; Zezula N; Kumari Jadaun A; Janovská P; Plešingerová H; Bryja V
    Front Cell Dev Biol; 2022; 10():911966. PubMed ID: 36561363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.
    Troeger A; Johnson AJ; Wood J; Blum WG; Andritsos LA; Byrd JC; Williams DA
    Blood; 2012 May; 119(20):4708-18. PubMed ID: 22474251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
    Laufer JM; Lyck R; Legler DF
    FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy.
    Pye DS; Rubio I; Pusch R; Lin K; Pettitt AR; Till KJ
    J Immunol; 2013 Aug; 191(3):1496-504. PubMed ID: 23804711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival.
    Nisticò N; Maisano D; Iaccino E; Vecchio E; Fiume G; Rotundo S; Quinto I; Mimmi S
    Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32937811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia.
    Caligaris-Cappio F; Bergui L; Tesio L; Corbascio G; Tousco F; Marchisio PC
    Blood; 1986 Jan; 67(1):233-9. PubMed ID: 3484425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice.
    Oldreive CE; Skowronska A; Davies NJ; Parry H; Agathanggelou A; Krysov S; Packham G; Rudzki Z; Cronin L; Vrzalikova K; Murray P; Odintsova E; Pratt G; Taylor AM; Moss P; Stankovic T
    Dis Model Mech; 2015 Nov; 8(11):1401-12. PubMed ID: 26398941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.